NCT02827071

Brief Summary

The purpose of this study is to evaluate this AngioScan angiography software on patients with various retinal vascular disorders. The advanced OCT instrument is an FDA approved clinically used camera, but the AngioScan angiography software is not FDA approved. Investigators would like to know if this imaging device and software can improve the quality of images and visualization of imaged tissues and whether they are useful in the diagnosis and treatment of eye diseases. Images collected in this study may be compared to other images collected as part of standard of care on the same patient (OCT, FA, AF, Fundus).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2016

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

July 6, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 11, 2016

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 9, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 9, 2021

Completed
Last Updated

April 20, 2026

Status Verified

July 1, 2016

Enrollment Period

5.4 years

First QC Date

July 6, 2016

Last Update Submit

April 16, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Retinal vascular abnormalities imaged by OCT Angiography and en face analysis of macular disorders

    2 years

Study Arms (1)

Retina abnormalities

Subjects with various retina vascular disorders

Eligibility Criteria

Age18 Years - 115 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects with retinal vascular abnormalities

You may qualify if:

  • Any patient with abnormal retinal findings as determined by investigators.

You may not qualify if:

  • Those suffering from head, neck or other injury which makes them unable to position themselves in head restraint for imaging.
  • Participants who are unable to maintain retinal fixation on a specified target.
  • Participants unable to achieve sufficient pupil dilation and alignment stability for imaging to take place.
  • Patients with media opacity which preclude high quality imaging.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stein Eye Institute/Geffen School of Medicine

Los Angeles, California, 90095, United States

Location

MeSH Terms

Conditions

Macular Degeneration

Condition Hierarchy (Ancestors)

Retinal DegenerationRetinal DiseasesEye Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 6, 2016

First Posted

July 11, 2016

Study Start

July 1, 2016

Primary Completion

December 9, 2021

Study Completion

December 9, 2021

Last Updated

April 20, 2026

Record last verified: 2016-07

Data Sharing

IPD Sharing
Will not share

Locations